Sangamo Announces Updated Phase 1/2 STAAR Study Data in Fabry Disease Showing Sustained Benefit, Improvements in Kidney Function and a Favorable Safety Profile

Click here to view

Presentation

Zinc Finger Activators restore normal gene and protein expression in a mouse model of SCN2A haploinsufficiency

Download PDF